Barclays
LJPC

Barclays’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,352
Closed -$17K 5041
2022
Q2
$17K Hold
5,352
﹤0.01% 4167
2022
Q1
$23K Sell
5,352
-12
-0.2% -$52 ﹤0.01% 4302
2021
Q4
$25K Sell
5,364
-2,340
-30% -$10.9K ﹤0.01% 3095
2021
Q3
$30K Sell
7,704
-6,863
-47% -$26.7K ﹤0.01% 3520
2021
Q2
$62K Sell
14,567
-516
-3% -$2.2K ﹤0.01% 3310
2021
Q1
$64K Buy
15,083
+9,251
+159% +$39.3K ﹤0.01% 3486
2020
Q4
$23K Sell
5,832
-2,563
-31% -$10.1K ﹤0.01% 3364
2020
Q3
$34K Sell
8,395
-2,236
-21% -$9.06K ﹤0.01% 3402
2020
Q2
$45K Buy
10,631
+3,635
+52% +$15.4K ﹤0.01% 3435
2020
Q1
$29K Sell
6,996
-14,824
-68% -$61.4K ﹤0.01% 3293
2019
Q4
$85K Buy
21,820
+6,073
+39% +$23.7K ﹤0.01% 3479
2019
Q3
$139K Buy
15,747
+1,585
+11% +$14K ﹤0.01% 3224
2019
Q2
$132K Buy
14,162
+8,029
+131% +$74.8K ﹤0.01% 3437
2019
Q1
$39K Sell
6,133
-34,776
-85% -$221K ﹤0.01% 3753
2018
Q4
$386K Sell
40,909
-100,899
-71% -$952K ﹤0.01% 2402
2018
Q3
$2.86M Buy
141,808
+138,889
+4,758% +$2.8M ﹤0.01% 1504
2018
Q2
$86K Sell
2,919
-708
-20% -$20.9K ﹤0.01% 3123
2018
Q1
$108K Buy
3,627
+855
+31% +$25.5K ﹤0.01% 3140
2017
Q4
$89K Sell
2,772
-7,221
-72% -$232K ﹤0.01% 3069
2017
Q3
$348K Sell
9,993
-3,477
-26% -$121K ﹤0.01% 2115
2017
Q2
$401K Buy
13,470
+11,200
+493% +$333K ﹤0.01% 2038
2017
Q1
$68K Buy
2,270
+2,065
+1,007% +$61.9K ﹤0.01% 2995
2016
Q4
$4K Sell
205
-138
-40% -$2.69K ﹤0.01% 3511
2016
Q3
$8K Buy
343
+285
+491% +$6.65K ﹤0.01% 3338
2016
Q2
$1K Hold
58
﹤0.01% 3574
2016
Q1
$1K Sell
58
-98
-63% -$1.69K ﹤0.01% 3423
2015
Q4
$4K Sell
156
-9,654
-98% -$248K ﹤0.01% 2966
2015
Q3
$265K Buy
9,810
+9,589
+4,339% +$259K ﹤0.01% 2014
2015
Q2
$5K Buy
+221
New +$5K ﹤0.01% 3671
2014
Q3
Sell
-3,600
Closed -$32K 4646
2014
Q2
$32K Buy
+3,600
New +$32K ﹤0.01% 3244